A rare case of apical hypertrophic cardiomyopathy (AHCM)

Seyed Abbas Mirabbasi1, Koroush Khalighi1,2, Suresh Mukkamala1

  • 1Department of Medicine, Easton Hospital, Drexel University School of Medicine, Easton, PA, USA.

Insights

Apical hypertrophic cardiomyopathy (AHCM) is a rare condition causing left ventricular thickening. This case highlights key ECG and echo findings crucial for diagnosing AHCM, even with nonspecific symptoms.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Apical hypertrophic cardiomyopathy (AHCM) is a distinct form of hypertrophic cardiomyopathy (HCM) characterized by distal left ventricular wall thickening.
  • While prevalent in Japan (15% of HCM cases), its incidence in the USA is lower (approx. 3% of HCM cases).

Observation:

  • A 46-year-old woman with hypertension presented with dyspnea and orthopnea.
  • Electrocardiogram (ECG) revealed left ventricular hypertrophy (LVH) and diffuse T-wave inversions.
  • Ventriculography demonstrated severe septal hypertrophy extending to the apex, causing a significant pressure gradient.

Findings:

  • Diagnostic findings confirmed severe concentric LVH with near obliteration of the left ventricular cavity.
  • A significant pressure gradient (≥160 mmHg) was noted from the apex to the mid-septal region.
  • These results were consistent with a diagnosis of apical hypertrophic cardiomyopathy.

Implications:

  • Despite variable clinical presentations, characteristic ECG and echocardiogram findings are vital for AHCM diagnosis.
  • The patient remained asymptomatic for 2.5 years following treatment with verapamil and metoprolol.
  • Early and accurate diagnosis through hallmark findings can guide effective management strategies for AHCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
655
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
542
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
647